Eurofins Scientific Se Stock Revenue
| ERFSF Stock | USD 53.92 0.48 0.88% |
Eurofins Scientific SE fundamentals help investors to digest information that contributes to Eurofins Scientific's financial success or failures. It also enables traders to predict the movement of Eurofins Pink Sheet. The fundamental analysis module provides a way to measure Eurofins Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eurofins Scientific pink sheet.
Eurofins |
Eurofins Scientific SE Company Revenue Analysis
Eurofins Scientific's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Eurofins Scientific Revenue | 6.72 B |
Most of Eurofins Scientific's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eurofins Scientific SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Eurofins Scientific SE reported 6.72 B of revenue. This is 11.92% lower than that of the Healthcare sector and 239.01% higher than that of the Diagnostics & Research industry. The revenue for all United States stocks is 28.8% higher than that of the company.
Eurofins Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eurofins Scientific's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Eurofins Scientific could also be used in its relative valuation, which is a method of valuing Eurofins Scientific by comparing valuation metrics of similar companies.Eurofins Scientific is currently under evaluation in revenue category among its peers.
Eurofins Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.075 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 15.96 B | |||
| Shares Outstanding | 192.56 M | |||
| Shares Owned By Insiders | 32.76 % | |||
| Shares Owned By Institutions | 36.56 % | |||
| Price To Earning | 21.61 X | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 1.95 X | |||
| Revenue | 6.72 B | |||
| Gross Profit | 1.91 B | |||
| EBITDA | 1.7 B | |||
| Net Income | 782.6 M | |||
| Cash And Equivalents | 718.8 M | |||
| Cash Per Share | 3.74 X | |||
| Total Debt | 2.08 B | |||
| Debt To Equity | 0.70 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 24.42 X | |||
| Cash Flow From Operations | 1.51 B | |||
| Earnings Per Share | 3.63 X | |||
| Price To Earnings To Growth | 29.46 X | |||
| Number Of Employees | 61 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 13.82 B | |||
| Total Asset | 9.33 B | |||
| Retained Earnings | 187 M | |||
| Working Capital | 669 M | |||
| Current Asset | 1.49 B | |||
| Current Liabilities | 818 M | |||
| Z Score | 3.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 9.33 B | |||
| Last Dividend Paid | 1.0 |
About Eurofins Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eurofins Scientific SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eurofins Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eurofins Scientific SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Eurofins Pink Sheet
Eurofins Scientific financial ratios help investors to determine whether Eurofins Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurofins with respect to the benefits of owning Eurofins Scientific security.